{"id":786,"date":"2020-08-26T09:31:58","date_gmt":"2020-08-26T09:31:58","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/t2-biosystems-hosts-integrated-symposium-at-eccmid-2019\/"},"modified":"2021-01-08T11:08:20","modified_gmt":"2021-01-08T11:08:20","slug":"t2-biosystems-hosts-integrated-symposium-at-eccmid-2019","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/t2-biosystems-hosts-integrated-symposium-at-eccmid-2019\/","title":{"rendered":"T2 Biosystems hosts integrated symposium at ECCMID 2019"},"content":{"rendered":"<p>T2 Biosystems, maker of rapid diagnostic technology to aid in the detection of blood stream infections to prevent sepsis, will host an integrated symposium at the European Congress of Clinical Microbiology &amp; Infectious Diseases (ECCMID) in Amsterdam, Monday, April 15, 16:00-18:00 CET. The symposium, \u201cRapid diagnostics direct from whole blood: a solution for fast and appropriate antimicrobial therapy\u201d, will feature leading clinicians and users of T2Direct Diagnostics\u2122 who will discuss integrating the Company\u2019s T2Bacteria<sup>\u00ae<\/sup> and T2Candida<sup>\u00ae<\/sup> Panels in clinical practice, and the product\u2019s potential to significantly improve antimicrobial stewardship and infectious disease management in clinical settings.<br \/>The panels are the first and only FDA-cleared and CE-marked tests that identify the most serious bacterial and fungal pathogens directly from blood sample in just three to five hours, without waiting for a positive blood culture \u2014which can take one to six or more days. These capabilities allow for faster species identification, enabling the potential for faster targeted treatment, de-escalation of empiric therapy and improved patient outcomes. <br \/>All T2Direct DiagnosticsTM panels are run on the T2Dx<sup>\u00ae<\/sup> Instrument using a patient\u2019s blood sample with validated clinical sensitivity of 91 to 96% and specificity of 98 to 99%. The direct from blood capability is enabled by the proprietary T2MR-powered T2Dx<sup>\u00ae<\/sup> Instrument which can detect organisms at concentrations as low as 1 CFU\/mL. This represents a thousandfold increase in sensitivity compared to products that detect species from positive blood culture bottles where the number of cells is typically in the range of 10,000 to 10,000,000 CFUs\/mL.<br \/>T2 Biosystems recently received FDA Breakthrough Designation for the T2ResistanceTM Panel, a diagnostic panel that can detect 13 resistance genes from both gram-positive and gram-negative pathogens from a single patient blood sample in 3 to 5 hours. The T2Resistance Panel is also run on the T2Dx instrument and is expected to be CE-marked and available in Europe by the end of 2019, and offered as a Research Use Only product in the United States before yearend. &nbsp;<br \/>T2 Biosystems will showcase its latest innovations at ECCMID at Booth #1.22. <\/p>\n<link http:\/\/www.T2Biosystems.com _blank external-link-new-window \"Opens internal link in current window\">www.T2Biosystems.com<\/link>\n","protected":false},"excerpt":{"rendered":"<p>T2 Biosystems, maker of rapid diagnostic technology to aid in the detection of blood stream infections to prevent sepsis, will host an integrated symposium at the European Congress of Clinical Microbiology &amp; Infectious Diseases (ECCMID) in Amsterdam, Monday, April 15, 16:00-18:00 CET. The symposium, \u201cRapid diagnostics direct from whole blood: a solution for fast and [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[35],"tags":[],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/786"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=786"}],"version-history":[{"count":0,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/786\/revisions"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=786"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=786"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=786"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}